Skip to content
DefDex

Federal award

PROGENICS PHARMACEUTICALS INC

W81K0022P0088

Contract

Obligated and Ceiling

Obligated (net)
$172,164.93
Ceiling (potential value, not spending)
$172,164.93
Current value
$172,164.93
Gross positive obligations
$172,164.93

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
PROGENICS PHARMACEUTICALS INC · YLYKVRPCTCR3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
LANTHEUS HOLDINGS, INC. · XKLLNAJB6LJ6
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
PIID
W81K0022P0088
Award type code
B
Actions
2 · Mar 11, 2022 to Jul 1, 2022
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History2

Award actions
DateFYModAction typeObligationCompany in company totals
Jul 1, 2022FY2022P00001M$0.00
—
Mar 11, 2022FY20220—$172,164.93
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.